Progyny, Inc. Interest Income, Debt Securities, Available-for-sale, Operating
Progyny, Inc. (PGNY) reported Interest Income, Debt Securities, Available-for-sale, Operating of $1.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeDebtSecuritiesAvailableForSaleOperating · last filed 2026-08-07
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for the quarter ending 2026-06-30 was $1.50M, a 37.50% decline year-over-year.
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for the quarter ending 2026-03-31 was $1.90M, a 17.39% decline year-over-year.
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for the quarter ending 2025-12-31 was $2.90M, a 45.00% increase year-over-year.
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for the quarter ending 2025-09-30 was $2.80M, a 68.54% decline year-over-year.
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for fiscal 2025 was $10.40M, a 16.13% decline from fiscal 2024.
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for fiscal 2024 was $12.40M, a 275.76% increase from fiscal 2023.
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for fiscal 2023 was $3.30M, a 312.50% increase from fiscal 2022.
- Progyny, Inc. interest income, debt securities, available-for-sale, operating for fiscal 2022 was $800.00K.
| Period end | Interest Income, Debt Securities, Available-for-sale, Operating 3 month | Interest Income, Debt Securities, Available-for-sale, Operating 6 month | Interest Income, Debt Securities, Available-for-sale, Operating 9 month | Interest Income, Debt Securities, Available-for-sale, Operating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.50M 10-Q · filed 2026-08-07 | $3.40M 10-Q · filed 2026-08-07 | $6.30M derived: sum of 3 quarters · filed 2026-08-07 | $9.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-08 | $4.80M derived: sum of 2 quarters · filed 2026-05-08 | $7.60M derived: sum of 3 quarters · filed 2026-05-08 | $10.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.70M derived: sum of 2 quarters · filed 2026-02-27 | $8.10M derived: sum of 3 quarters · filed 2026-08-07 | $10.40M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.80M 10-Q · filed 2025-11-07 | $5.20M derived: sum of 2 quarters · filed 2026-08-07 | $7.50M 10-Q · filed 2025-11-07 | $9.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-07 | $4.70M 10-Q · filed 2026-08-07 | $6.70M derived: sum of 3 quarters · filed 2026-08-07 | $15.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.30M 10-Q · filed 2026-05-08 | $4.30M derived: sum of 2 quarters · filed 2026-05-08 | $13.20M derived: sum of 3 quarters · filed 2026-05-08 | $14.00M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.90M derived: sum of 2 quarters · filed 2026-02-27 | $11.70M derived: sum of 3 quarters · filed 2026-02-27 | $12.40M 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.90M 10-Q · filed 2025-11-07 | $9.70M derived: sum of 2 quarters · filed 2025-11-07 | $10.40M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $800.00K 10-Q · filed 2025-08-08 | $1.40M 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $600.00K 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $3.30M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $800.00K 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |